SLG
OXFD

Stanley-Laman Group’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Stanley-Laman Group’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-49,514
Closed -$692K – 293
2017
Q4 		$692K Buy
+49,514
New +$725K 0.15% 190

Other funds holding OXFD

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Stanley-Laman Group's OXFD Position: Q1 2018 in Review

Stanley-Laman Group sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2018, closing a stake of 49,514 shares — an estimated $692K sold.

Stanley-Laman Group first reported a position in OXFD in Q4 2017 and held it in 1 quarter. The position peaked at $692K in Q4 2017. 74 funds tracked by Wall St. Rank hold OXFD as of Q1 2018.

  • Stanley-Laman Group reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2018 after selling out during the quarter.
  • Stanley-Laman Group sold 49,514 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2018, an estimated $692K.
  • Stanley-Laman Group first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2017 and held it in 1 quarter.
  • Stanley-Laman Group's Oxford Immunotec Global PLC Ordinary Shares position peaked at $692K in Q4 2017.
  • 74 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2018.

Based on Stanley-Laman Group's 13F filing for Q1 2018, filed 1 May 2018.